Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.

Fumet, Jean-David; Richard, Corentin; Ledys, Fanny; Klopfenstein, Quentin; Joubert, Philippe; Routy, Bertrand; Truntzer, Caroline; Gagné, Andréanne; Hamel, Marc-André; Guimaraes, Camila Figueiredo; Coudert, Bruno; Arnould, Laurent; Favier, Laure; Lagrange, Aurélie; Ladoire, Sylvain; Saintigny, Pierre; Ortiz-Cuaran, Sandra; Perol, Maurice; Foucher, Pascal; Hofman, Paul; Ilie, Marius; Chevrier, Sandy; Boidot, Romain; Derangere, Valentin; Ghiringhelli, François

Fumet, Jean-David; Richard, Corentin; Ledys, Fanny; Klopfenstein, Quentin; Joubert, Philippe; Routy, Bertrand; Truntzer, Caroline; Gagné, Andréanne; Hamel, Marc-André; Guimaraes, Camila Figueiredo; Coudert, Bruno; Arnould, Laurent; Favier, Laure; Lagrange, Aurélie; Ladoire, Sylvain; Saintigny, Pierre; Ortiz-Cuaran, Sandra; Perol, Maurice; Foucher, Pascal; Hofman, Paul; Ilie, Marius; Chevrier, Sandy; Boidot, Romain; Derangere, Valentin; Ghiringhelli, François.

Afiliação

Fumet JD; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
Richard C; Research Platform in Biological Oncology, Dijon, France.
Ledys F; GIMI Genetic and Immunology Medical Institute, Dijon, France.
Klopfenstein Q; University of Burgundy-Franche Comté, Dijon, France.
Joubert P; Research Platform in Biological Oncology, Dijon, France.
Routy B; GIMI Genetic and Immunology Medical Institute, Dijon, France.
Truntzer C; University of Burgundy-Franche Comté, Dijon, France.
Gagné A; Research Platform in Biological Oncology, Dijon, France.
Hamel MA; GIMI Genetic and Immunology Medical Institute, Dijon, France.
Guimaraes CF; University of Burgundy-Franche Comté, Dijon, France.
Coudert B; Research Platform in Biological Oncology, Dijon, France.
Arnould L; GIMI Genetic and Immunology Medical Institute, Dijon, France.
Favier L; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.
Lagrange A; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
Ladoire S; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada.
Saintigny P; Research Platform in Biological Oncology, Dijon, France.
Ortiz-Cuaran S; GIMI Genetic and Immunology Medical Institute, Dijon, France.
Perol M; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.
Foucher P; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.
Hofman P; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.
Ilie M; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
Chevrier S; Department of Pathology, Center GF Leclerc, Dijon, France.
Boidot R; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
Derangere V; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
Ghiringhelli F; Department of Medical Oncology, Center GF Leclerc, Dijon, France.

Br J Cancer ; 121(3): 283, 2019 Jul.

Article em En | MEDLINE | ID: mdl-31235866

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Br J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google